Eloxx Pharmaceuticals, Inc. · NASDAQ:ELOX
Domicilium Capital Partners LLC's stake in Eloxx Pharmaceuticals, Inc. fell to 4.90% (Schedule 13G/A)
Event May 27, 2026 · Filed Jun 5, 2026
Domicilium Capital Partners LLC's stake in Eloxx Pharmaceuticals, Inc. fell to 4.90%, 23,478 shares, as a passive investor on May 27, 2026. Filed Jun 5, 2026 (Schedule 13G/A).
- Stake
- 4.90%
- Shares
- 23,478
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Domicilium Real Estate Fund III LP | 2.00% | 9,193 |
| Domicilium Real Estate Fund III GP LLC | 2.00% | 9,193 |
| Domicilium Capital Partners LLC | 4.90% | 23,478 |
| Daniel Simon | 4.90% | 23,478 |
Source
Related
- Eloxx Pharmaceuticals, Inc.
- Domicilium Capital Partners LLC
- Eloxx Pharmaceuticals, Inc. shareholders
- Schedule 13G · Domicilium Capital Partners LLC · Jun 17, 2026
- Schedule 13G · Nantahala Capital Management, LLC · Aug 14, 2026
- Schedule 13G · Srinivas Akkaraju · Aug 14, 2026
- Schedule 13G · EcoR1 Capital, LLC · Jun 16, 2026
- Schedule 13G · Stonepine Capital Management, LLC · Jun 16, 2026
- Schedule 13G · Invus Public Equities, L.P. · Jun 15, 2026